World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
20069
World Ranking
16311
National Ranking
8204

Charles B. Pratt publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles B. Pratt sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 298 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles B. Pratt D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles B. Pratt sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles B. Pratt was affiliated with St. Jude Children's Research Hospital in the United States. Their career was associated with this institution, where they contributed to research efforts within the scope of the hospital's focus.

There are no specific records of recent papers published by Charles B. Pratt. Likewise, information on frequent co-authors, publication venues, book publications, main fields, subfields of study, or main topics of work is not available from existing data.

No awards or distinctions have been documented for this scientist.

Charles B. Pratt is deceased. The profile reflects the historical and factual overview based on available information.

Best Publications

  • The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity

    M P Link;A M Goorin;A W Miser;A A Green

  • Successful Chemoprophylaxis for Pneumocystis carinii Pneumonitis

    Walter T. Hughes;Shirley Kuhn;Subhash Chaudhary;Sandor Feldman

  • Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia.

    Rhomes J. A. Aur;Joseph Simone;H. Omar Hustu;Thomas Walters

  • Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.

    John F. Kuttesch;Leonard H. Wexler;Robert B. Marcus;Diane Fairclough

  • High-Dose Methotrexate-Induced Nephrotoxicity in Patients with Osteosarcoma: Incidence, Treatment, and Outcome

    Brigitte C. Widemann;Frank M. Balis;Beate Kempf-Bielack;Stefan Bielack

  • Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research hospital

    Andrew W. Walter;Michael L. Hancock;Ching Hon Pui;Melissa M. Hudson

  • Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children

    Wayne L. Furman;Clinton F. Stewart;Catherine A. Poquette;Charles B. Pratt

  • Drug dosage and remission duration in childhood lymphocytic leukemia.

    Donald Pinkel;Kathleen Hernandez;Luis Borella;Charlene Holton

  • Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features.

    Sue C. Kaste;Sue C. Kaste;Charles B. Pratt;Charles B. Pratt;Alvida M. Cain;Dana J. Jones-Wallace

  • Treatment of intraocular retinoblastoma with vincristine and carboplatin

    Carlos Rodriguez-Galindo;Matthew W. Wilson;Barrett G. Haik;Thomas E. Merchant

  • Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999.

    Carlos Rodriguez-Galindo;Carlos Rodriguez-Galindo;Catherine A. Billups;Larry E. Kun;Larry E. Kun;Bhaskar N. Rao;Bhaskar N. Rao

  • Coordinated Treatment of Childhood Rhabdomyosarcoma with Surgery, Radiotherapy, and Combination Chemotherapy

    Pratt Cb;Hustu Ho;Fleming Id;Pinkel D

  • Malignant germ cell tumors in 57 children and adolescents.

    Garrett M. Brodeur;Cathryn B. Howarth;Charles B. Pratt;Josefina Caces

  • Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors.

    Daryl S. Sonnichsen;Craig A. Hurwitz;Charles B. Pratt;Jonathan J. Shuster

  • Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital.

    Sheri L. Spunt;Catherine A. Poquette;Yasmeen S. Hurt;Alvida M. Cain

  • Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.

    Orren Beaty;Melissa M. Hudson;Carol Greenwald;Xiaolong Luo

  • Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study.

    David G. Tubergen;Clinton F. Stewart;Charles B. Pratt;William C. Zamboni

  • Phase I study of topotecan for pediatric patients with malignant solid tumors.

    C B Pratt;C Stewart;V M Santana;L Bowman

  • Ifosfamide, Fanconi's syndrome, and rickets.

    Charles B. Pratt;William H. Meyer;Jesse J. Jenkins;Loraine Avery

  • Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study.

    Ruprecht Nitschke;Joan Parkhurst;James Sullivan;Michael B. Harris

Frequent Co-Authors

Alberto S. Pappo
Alberto S. Pappo St. Jude Children's Research Hospital
Larry E. Kun
Larry E. Kun St. Jude Children's Research Hospital
David M. Parham
David M. Parham Children's Hospital of Los Angeles
Gaston K. Rivera
Gaston K. Rivera St. Jude Children's Research Hospital
Thomas E. Merchant
Thomas E. Merchant St. Jude Children's Research Hospital
William E. Evans
William E. Evans St. Jude Children's Research Hospital
Clinton F. Stewart
Clinton F. Stewart St. Jude Children's Research Hospital
Melissa M. Hudson
Melissa M. Hudson St. Jude Children's Research Hospital
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Mary V. Relling
Mary V. Relling St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online health care degrees is an excellent option for aspiring medical professionals. Nursing is among the most popular and flexible career paths. Many students search what is the cheapest online college for nursing? to help minimize costs while earning a respected credential.

For those seeking advanced opportunities, pursuing a phd in nursing can open doors to research, teaching, and leadership roles. If you are already an RN, the cheapest online bsn programs provide a streamlined way to enhance your qualifications and career prospects.

Non-nursing majors interested in entering the field quickly may benefit from direct entry msn programs for non-nursing majors online. These accelerated pathways make it possible to change careers and gain a master’s-level nursing education without a prior nursing degree. Researching online programs and their affordability is crucial when planning your next steps in healthcare education.

Best Scientists Citing Charles B. Pratt

Recently Published Articles